German Ablation Quality-Register

NCT ID: NCT01197638

Last Updated: 2016-06-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20663 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-06-30

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this register is the documentation of the success as well as of the complications regarding interventional therapy of cardiac arrhythmia by catheter ablation. This is the necessary basis for quality management and development of possible improvements of catheter ablation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The interventional therapy of heartbeat disturbances by means of catheter ablation makes the curative treatment possible of numerous tachycardiac arrhythmics. By this crucial improvement of the supply of patients and its quality of life a genuine healing of a multiplicity of heartbeat disturbances became possible. Especially within the range of the ablation treatment there are relatively few con-trolled studies, which would give a broad collection of the results of the catheter ablation in the different indication areas.

Aim of the registry:

Documentation of indication, hospital course and complications during long term follow-up of patients with catheter ablation

Design:

Prospective, multicenter registry; FU-duration 12 months.

Duration:

Phase I: 2 years

Inclusion criteria:

Catheter ablation (intention to treat)

Exclusion criteria:

Missing declaration of consent

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arrhythmia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The ablation register will include all consecutive patients with a performed or attempted electrophysiological ablation

Exclusion Criteria

* Missing signed informed consent
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stiftung Institut fuer Herzinfarktforschung

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jochen Senges, MD

Role: PRINCIPAL_INVESTIGATOR

Stiftung Institut fuer Herzinfarktforschung

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Herz- und Gefäßklinik

Bad Neustadt / Saale, , Germany

Site Status

Vivantes Klinikum Am Urban

Berlin, , Germany

Site Status

St. Marien Hospital

Bonn, , Germany

Site Status

Klinikum Coburg

Coburg, , Germany

Site Status

Praxisklinik Herz und Gefäß,

Dresden, , Germany

Site Status

Asklepios Klinik St Georg

Hamburg, , Germany

Site Status

Universitäres Herzzentrum Hamburg

Hamburg, , Germany

Site Status

Städt Klinikum Hildesheim

Hildesheim, , Germany

Site Status

Krankenhaus München Bogenhausen

München, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Schleberger R, Metzner A, Kuck KH, Andresen D, Willems S, Hoffmann E, Deneke T, Eckardt L, Brachmann J, Hochadel M, Senges J, Rillig A. Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry. Pharmacol Res Perspect. 2021 Dec;9(6):e00880. doi: 10.1002/prp2.880.

Reference Type DERIVED
PMID: 34664789 (View on PubMed)

Dechering DG, Gonska BD, Brachmann J, Lewalter T, Kuck KH, Andresen D, Willems S, Spitzer SG, Straube F, Schumacher B, Hochadel M, Senges J, Eckardt L. Efficacy and complications of cavo-tricuspid isthmus-dependent atrial flutter ablation in patients with and without structural heart disease: results from the German Ablation Registry. J Interv Card Electrophysiol. 2021 Jun;61(1):55-62. doi: 10.1007/s10840-020-00769-z. Epub 2020 May 27.

Reference Type DERIVED
PMID: 32458180 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ablations Register

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

DiamondTemp Global Registry
NCT04735016 RECRUITING
Electrocardiographic Mapping and Imaging
NCT01394965 WITHDRAWN EARLY_PHASE1